Abi Microforms And Intergrated Cirucits Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.85 M
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.90 Cr
- Revenue Growth %
- Profit Growth 0.33%
- Ebitda 0.33%
- Net Worth -0.65%
- Total Assets -0.01%
About Abi Microforms And Intergrated Cirucits
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U32105DL1989PTC035539
-
Company No.
035539
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Mar 1989
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Abi Microforms And Intergrated Cirucits?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Gupta
![]() |
Additional Director | 03-Jul-2024 | Current |
Dheeraj Gupta
![]() |
Director | 24-Dec-2004 | Current |
Financial Performance of Abi Microforms And Intergrated Cirucits.
Abi Microforms And Intergrated Cirucits Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.33% increase in profit. The company's net worth dipped by a decrease of 0.65%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Abi Microforms And Intergrated Cirucits?
In 2019, Abi Microforms And Intergrated Cirucits had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹0
₹39.02 M
Charges Breakdown by Lending Institutions
- Religare Finvest Limited : 3.35 Cr
- Karnataka Bank Ltd. : 0.55 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Feb 2024 | Karnataka Bank Ltd. | ₹5.50 M | Satisfied |
16 Jun 2009 | Religare Finvest Limited | ₹3.35 Cr | Satisfied |
How Many Employees Work at Abi Microforms And Intergrated Cirucits?
Unlock and access historical data on people associated with Abi Microforms And Intergrated Cirucits, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Abi Microforms And Intergrated Cirucits, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abi Microforms And Intergrated Cirucits's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.